Robin Lloyd is a freelance writer, editor and educator, as well as a contributing editor for Scientific American and an adjunct professor at New York University’s Science, Health and Environmental Reporting Program. She has a Ph.D. and M.A. in sociology from the University of California, Santa Barbara, and a B.A. from Smith College. She completed a Knight Science Journalism Fellowship at the Massachusetts Institute of Technology for the 1998-1999 academic year.
Robin Lloyd
Locum News Editor
Spectrum
From this contributor
Sounding out ultrasounds; name game; geek gathering
A tie between first-trimester ultrasounds and autism severity is tenuous at best, misnamed genes litter the literature, and neuroscientists enjoy their version of summer camp.
Sounding out ultrasounds; name game; geek gathering
By
Robin Lloyd
9 September 2016 | 5 min read
Calming remedies; labor lessons; women wanted
New drugs target the brain’s calming chemical, inducing labor does not boost autism risk, and the start is imminent for a project to develop personalized treatments.
Fake facilitation; third strike; Pokémon passion
An autism researcher retracts her third paper in as many years, scientists write fraudulent reviews of their own papers, and Pokémon Go boosts social skills in children with autism.
Brexit break-ups; little impact; micro medicine
Scientists are excluding U.K. colleagues from studies; a life sciences publisher abandons the ‘impact factor;’ and a new open-access journal makes its debut.
CRISPR medicine; inclusive experiments; autism in Egypt
Scientists target human cancer with CRISPR, device trials may become more diverse, and autism awareness grows in Egypt.
CRISPR medicine; inclusive experiments; autism in Egypt
By
Robin Lloyd
24 June 2016 | 4 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read